Mike Ouimette's Insider Trades & SAST Disclosures
Mike Ouimette's most recent trade in Pliant Therapeutics Inc was a trade of 70,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 23, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Mike Ouimette.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 70,000 | 70,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 35,000 | 105,544 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 11.20 per share. | 17 Jan 2025 | 13,270 | 80,774 | - | 11.2 | 148,639 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 10.99 per share. | 17 Jan 2025 | 10,230 | 70,544 | - | 11.0 | 112,462 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 11.56 per share. | 10 Jul 2024 | 7,656 | 94,044 | - | 11.6 | 88,503 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 14,954 | 101,700 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Ouimette Mike | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 31,500 | 86,746 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Ouimette Mike | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 17.23 per share. | 17 Jan 2024 | 5,197 | 55,246 | - | 17.2 | 89,544 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 17.55 per share. | 20 Jul 2023 | 4,755 | 60,443 | - | 17.5 | 83,450 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 17 Jul 2023 | 12,778 | 65,198 | - | 18.0 | 230,120 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 27,187 | 77,976 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 26.52 per share. | 30 Mar 2023 | 4,874 | 53,666 | - | 26.5 | 129,263 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 26.74 per share. | 30 Mar 2023 | 2,677 | 50,989 | - | 26.7 | 71,575 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 27.46 per share. | 30 Mar 2023 | 200 | 50,789 | - | 27.5 | 5,491 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2023 | 13,593 | 58,540 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 55,000 | 55,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2023 | 39,000 | 44,947 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 34.19 per share. | 23 Jan 2023 | 20,000 | 5,947 | - | 34.2 | 683,878 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 10,000 | 98,240 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jan 2023 | 10,000 | 77,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 24.32 per share. | 23 Jan 2023 | 10,000 | 25,947 | - | 24.3 | 243,200 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.86 per share. | 23 Jan 2023 | 10,000 | 15,947 | - | 11.9 | 118,600 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 19.38 per share. | 22 Dec 2022 | 2,928 | 5,947 | - | 19.4 | 56,731 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2022 | 13,594 | 13,594 | - | 0 | Common Stock | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Sale of securities on an exchange or to another person at price $ 19.10 per share. | 19 Dec 2022 | 4,719 | 8,875 | - | 19.1 | 90,144 | Common Stock |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2022 | 87,000 | 87,000 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel & Corp. Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2021 | 15,520 | 15,520 | - | - | Stock Option (right to buy) | |
| Pliant Therapeutics Inc | Mike Ouimette | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2020 | 108,240 | 108,240 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges